Structural Basis of the Antiproliferative Activity of Largazole, a Depsipeptide Inhibitor of the Histone Deacetylases
journal contributionposted on 17.08.2011, 00:00 by Kathryn E. Cole, Daniel P. Dowling, Matthew A. Boone, Andrew J. Phillips, David W. Christianson
Largazole is a macrocyclic depsipeptide originally isolated from the marine cyanobacterium Symploca sp., which is indigenous to the warm, blue-green waters of Key Largo, Florida (whence largazole derives its name). Largazole contains an unusual thiazoline–thiazole ring system that rigidifies its macrocyclic skeleton, and it also contains a lipophilic thioester side chain. Hydrolysis of the thioester in vivo yields largazole thiol, which exhibits remarkable antiproliferative effects and is believed to be the most potent inhibitor of the metal-dependent histone deacetylases (HDACs). Here, the 2.14 Å-resolution crystal structure of the HDAC8–largazole thiol complex is the first of an HDAC complexed with a macrocyclic inhibitor and reveals that ideal thiolate–zinc coordination geometry is the key chemical feature responsible for its exceptional affinity and biological activity. Notably, the core structure of largazole is conserved in romidepsin, a depsipeptide natural product formulated as the drug Istodax recently approved for cancer chemotherapy. Accordingly, the structure of the HDAC8–largazole thiol complex is the first to illustrate the mode of action of a new class of therapeutically important HDAC inhibitors.
Read the peer-reviewed publication
macrocyclic inhibitorAntiproliferative Activitymacrocyclic skeletondrug Istodaxlipophilic thioester side chaincancer chemotherapyStructural BasisHDAC complexedchemical featuremacrocyclic depsipeptidevivo yields largazole thiolantiproliferative effectsKey LargoDepsipeptide InhibitorHDAC inhibitorscore structureHistone DeacetylasesLargazole